Results 21 to 30 of about 5,029 (162)

Vojislav Arnovljević described "Sézary syndrome" ten years before Sézary and Bouvrain [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2016
In 1938 Sezary and Bouvrain reported on a patient with a set of symptoms which later began to carry an eponymous designation “Sezary syndrome.” Ten years previously, Vojislav Arnovljević had described a patient with exactly the same set of ...
Čolović Nataša, Janković Marko, Leković Danijela, Gotić Mirjana   +3 more
doaj   +1 more source

A mouse model for the Sézary syndrome

Journal of Experimental & Clinical Cancer Research, 2010
Background The Sézary syndrome is an aggressive leukemic form of cutaneous T cell lymphoma and there is no cure of this disease. Until now there is no true animal model for Sézary syndrome, by which new drugs against the disease could be tested.
Doebbeling Udo
doaj   +1 more source

Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System

Cells, 2022
Sézary syndrome is a rare subtype of cutaneous T-cell lymphoma characterized by erythroderma, peripheral lymphadenopathies, and circulating atypical cerebriform T-cells. To date, no definite staging system has been developed for these patients.
Gabriele Roccuzzo, Silvia Giordano, Gianluca Avallone, Marco Rubatto, Silvia Canonico, Ada Funaro, Erika Ortolan, Rebecca Senetta, Paolo Fava, Maria Teresa Fierro, Simone Ribero, Pietro Quaglino   +11 more
doaj   +1 more source

Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome

Cells, 2020
Sézary syndrome (SS), an aggressive cutaneous T-cell lymphoma (CTCL) with poor prognosis, is characterized by the clinical hallmarks of circulating malignant T cells, erythroderma and lymphadenopathy. However, highly variable clinical skin manifestations
Andrea Moerman-Herzog, Syed J. Mehdi, Henry K. Wong   +2 more
doaj   +1 more source

Síndrome de Sézary.

Acta Médica Portuguesa, 1998
Sézary syndrome is a form of cutaneous T-cell lymphoma and, like mycosis fungoides, results from the malignant proliferation of mature post-thymic T-cell lymphocytes.
F Ferreira, T M Correia, L Callabro, J Andrade   +3 more
doaj   +1 more source

Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark

Acta Dermato-Venereologica, 2019
Diagnosis of mycosis fungoides and Sézary syndrome can be very challenging. Clinical and histopathological data for patients with mycosis fungoides and Sézary syndrome in Denmark are limited.
Pia Rude Nielsen, Jens Ole Eriksen, Ulrike Wehkamp, Lise Maria Lindahl, Robert Gniadecki, Hanne Fogh, Susanne Fabricius, Michael Bzorek, Niels Ødum, Lise Mette Gjerdrum   +9 more
doaj   +1 more source

Successful Treatment of Erythroderma in a Psoriasis Patient, Developed After Anti‐IL‐17, Anti‐IL‐23 and Anti‐IL‐4/IL‐13 Treatment, With Deucravacitinib

JEADV Clinical Practice, EarlyView.
ABSTRACT We present the case of a 79‐year‐old female patient diagnosed with psoriasis who developed paradoxical drug reactions after administration of anti‐IL17 and anti‐IL‐23 inhibitors. Having shifted towards a rather eczematous phenotype, the patient received an anti‐IL‐4/IL‐3 inhibitor, subsequently developing erythroderma.
Tugce Guel, Luka de Vos‐Hillebrand, Dagmar Wilsmann‐Theis, Natalija Novak, Joerg Wenzel   +4 more
wiley   +1 more source

Itch in patients with cutaneous T-cell lymphoma as a quality of life indicatorCapsule Summary

JAAD International, 2022
Background: Cutaneous T-cell lymphoma (CTCL) is a chronic and progressive disease that has a major impact on quality of life (QoL). Objectives: To describe the impact of the different stages of disease in patients with classical mycosis fungoides ...
Rosanne Ottevanger, MD, Sylvia van Beugen, MSc, PhD, Andrea W.M. Evers, MSc, PhD, Rein Willemze, MD, PhD, Maarten H. Vermeer, MD, PhD, Koen D. Quint, MD, PhD   +5 more
doaj  

The role of 9-O-acetylated ganglioside D3 (CD60) and α4β1 (CD49d) expression in predicting the survival of patients with Sézary syndrome

Haematologica, 2010
Background Sézary syndrome is a rare and very aggressive leukemic variant of cutaneous T-cell lymphoma characterized by extensive skin involvement and a malignant circulating CD4+ T-cell clone which homes to the skin, over-expresses CD60, and lacks CD7 ...
Enrico Scala, Damiano Abeni, Debora Pomponi, Maria Grazia Narducci, Giuseppe Alfonso Lombardo, Adriano Mari, Marina Frontani, Maria Cristina Picchio, Maria Antonietta Pilla, Elisabetta Caprini, Giandomenico Russo   +10 more
doaj   +1 more source

Defining Core Concepts for Health‐Related Quality of Life for Patients With Mycosis Fungoides and Sézary Syndrome: A Systematic Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background There is no consensus on how best to assess the impact of living with mycosis fungoides (MF)/Sézary syndrome (SS) on a patient's quality of life. Objectives To identify all potential concepts that describe disease severity or contribute to health‐related quality of life (HRQOL) from patients with MF/SS and their care partners ...
Christina Asare, Jennifer Chen, Pragna Naidoo, Caroline Raymundo, Marianne Tawa, Nilufer Khan, Elise Olsen, Rosanne Ottevanger, Julia Scarisbrick, Susan Thornton, Ellen J. Kim, Cecilia Larocca, Michi M. Shinohara, International Dermatology Outcomes Measures (IDEOM) CTCL Workgroup   +13 more
wiley   +1 more source